NCT07803848
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07803848
Title Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance Status (SPACE-T)
Acronym SPACE-T
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AIO-Studien-gGmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.